Canada markets open in 4 hours 26 minutes

Evome Medical Technologies Inc. (LNDZF)

OTC Markets OTCPK - OTC Markets OTCPK Delayed Price. Currency in USD
Add to watchlist
0.05210.0000 (0.00%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close0.0000
Open0.1000
Bid0.0400 x 0
Ask0.2230 x 0
Day's Range0.1000 - 0.1000
52 Week Range0.0111 - 0.2100
Volume10,000
Avg. Volume1,272
Market Cap8.545M
Beta (5Y Monthly)1.90
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateMay 24, 2017
1y Target EstN/A
  • GlobeNewswire

    Evome Medical Technologies Reviews Highlights of Low-CapEx Revenue Growth Plan

    Posts updated corporate presentation to website Reminder: Conference call to be held on August 19th to discuss Q2 2024 financial results SHIRLEY, N.Y., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) highlights its low-CapEx plan for growing revenue in an updated corporate presentation now available at www.evomemedical.com/investor. The presentation, to be used during investor meetings planned for next month in New York, Vancouver, Montre

  • GlobeNewswire

    Evome Medical Technologies Reports Second Quarter 2024 Financial Results

    Stabilizes business with a return to positive Adjusted EBITDAPromotes Gordon Bean to Chief Financial OfficerAnnounces August 19th conference call to discuss financial results SHIRLEY, N.Y., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. ‎(the “Company” or “Evome”) (TSXV: EVMT) today reported financial results for the second quarter ended June 30, 2024, featuring $421,000 in positive Adjusted EBITDA1, a reduction in debt, financial performance momentum and significant progress

  • GlobeNewswire

    Evome Medical Technologies Retains irlabs for Investor Relations Services

    NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- Evome Medical Technologies Inc. (the “Company” or “Evome”) (TSXV: EVMT) is pleased to announce it has entered into an agreement ("Agreement") with IR Labs Inc. ("irlabs") to provide the Company with investor relations and communications services. “We look forward to this partnership with irlabs as we work to raise our profile in the investment community,” said Mike Seckler, CEO. “In tandem with their expert team, we’re confident we can amplify our stor